HK1208092A1 - Multimarker risk stratification - Google Patents

Multimarker risk stratification

Info

Publication number
HK1208092A1
HK1208092A1 HK15108723.0A HK15108723A HK1208092A1 HK 1208092 A1 HK1208092 A1 HK 1208092A1 HK 15108723 A HK15108723 A HK 15108723A HK 1208092 A1 HK1208092 A1 HK 1208092A1
Authority
HK
Hong Kong
Prior art keywords
risk stratification
multimarker risk
multimarker
stratification
risk
Prior art date
Application number
HK15108723.0A
Other languages
English (en)
Chinese (zh)
Inventor
James V Snider
Robert W Gerwien
Sven Jacobson
Original Assignee
Critical Care Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Critical Care Diagnostics Inc filed Critical Critical Care Diagnostics Inc
Publication of HK1208092A1 publication Critical patent/HK1208092A1/xx

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HK15108723.0A 2012-08-21 2015-09-08 Multimarker risk stratification HK1208092A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691706P 2012-08-21 2012-08-21
PCT/US2013/056020 WO2014031764A1 (en) 2012-08-21 2013-08-21 Multimarker risk stratification

Publications (1)

Publication Number Publication Date
HK1208092A1 true HK1208092A1 (en) 2016-02-19

Family

ID=50148799

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15108723.0A HK1208092A1 (en) 2012-08-21 2015-09-08 Multimarker risk stratification
HK15112621.5A HK1212057A1 (en) 2012-08-21 2015-12-23 Multimarker risk stratification

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15112621.5A HK1212057A1 (en) 2012-08-21 2015-12-23 Multimarker risk stratification

Country Status (12)

Country Link
US (4) US20140058743A1 (ja)
EP (1) EP2888687B1 (ja)
JP (3) JP6450679B2 (ja)
CN (2) CN104737170A (ja)
AU (3) AU2013305829A1 (ja)
CA (1) CA2882303A1 (ja)
HK (2) HK1208092A1 (ja)
IN (1) IN2015DN01767A (ja)
MX (2) MX2015002254A (ja)
RU (1) RU2015110054A (ja)
SG (2) SG11201501271TA (ja)
WO (1) WO2014031764A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432060B2 (en) 2000-11-09 2008-10-07 The Brigham And Women's Hospital, Inc. Methods for diagnosis of cardiovascular disease
ES2573471T3 (es) 2002-05-09 2016-06-08 The Brigham And Women's Hospital, Inc. 1L1RL-1 como un marcador de enfermedades cardiovasculares
JP5383480B2 (ja) 2006-04-24 2014-01-08 クリティカル ケア ダイアグノスティクス インコーポレイテッド 致死性の予測および重大な疾患の検出
EP2482078B1 (en) 2006-05-01 2016-02-03 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
EP3093663B1 (en) 2008-04-18 2018-06-13 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
EP2556090B1 (en) * 2010-04-09 2016-02-24 Critical Care Diagnostics, Inc. Soluble human st-2 antibodies and assays
CN106940375B (zh) 2011-03-17 2019-03-08 重症监护诊断股份有限公司 预测不良临床结果的风险的方法
DK2734222T3 (en) 2011-07-18 2017-01-30 Critical Care Diagnostics Inc PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY
EP3434260A1 (en) 2012-05-18 2019-01-30 Critical Care Diagnostics, Inc. Methods for treating or predicting risk of ventricular tachyarrhythmia event
WO2014028875A1 (en) 2012-08-16 2014-02-20 Critical Care Diagnostics, Inc. Methods for predicting risk of developing hypertension
SG11201501271TA (en) 2012-08-21 2015-03-30 Critical Care Diagnostics Inc Multimarker risk stratification
CA2935958A1 (en) * 2014-01-10 2015-07-16 Critical Care Diagnostics, Inc. Methods and systems for determining risk of heart failure
US10079073B2 (en) 2014-12-11 2018-09-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker
US10324089B2 (en) 2014-12-11 2019-06-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker
WO2017035639A1 (en) 2015-08-28 2017-03-09 Mcmaster University Method of determining risk of an adverse cardiac event
US20170220749A1 (en) * 2016-02-01 2017-08-03 MD Aware LLC Systems and methods for identifying and using medical calculators
BR112018071395A2 (pt) * 2016-04-18 2019-02-05 Centre Dinvestigation Clinique Plurithematique Pierre Drouin Inserm Chu De Nancy Inst Lorrain Du Coe métodos de identificação de pacientes, método de previsão do risco de progressão para lvh, método de diferenciação em pacientes, métodos de previsão se pacientes se encontram com risco de progressão para lvh e uso
RU2677611C1 (ru) * 2018-04-16 2019-01-17 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ прогнозирования неблагоприятных сердечно-сосудистых событий в течение 12 месяцев у больных хронической сердечной недостаточностью с рецидивом стенокардии после реваскуляризации миокарда
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
WO2021084747A1 (ja) * 2019-11-01 2021-05-06 日本電気株式会社 リスク予測装置、リスク予測方法、及びコンピュータプログラム

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US5206140A (en) 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
JPH0731479Y2 (ja) 1989-06-02 1995-07-19 内橋エステック株式会社 温度ヒューズ
US5217899A (en) 1990-08-24 1993-06-08 The General Hospital Corporation Cell stretching apparatus
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
JP2732005B2 (ja) 1992-12-14 1998-03-25 眞一 富永 ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法
US6066322A (en) 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
CA2263832A1 (en) 1996-08-23 1998-02-26 Human Genome Sciences, Inc. T1 receptor-like ligand ii
US20020111472A1 (en) 1997-02-28 2002-08-15 Jian Ni T1-r ligand iii
ES2239801T3 (es) 1997-04-02 2005-10-01 The Brigham And Women's Hospital, Inc. Uso de un agente para disminuir el riesgo de enfermedad cardiovascular.
AU7590198A (en) 1997-06-10 1998-12-30 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
CA2304263C (en) 1997-09-11 2008-07-29 Shionogi & Co., Ltd. Immunoassay method for bnp
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
GB9827348D0 (en) 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
AU2055300A (en) 1998-12-18 2000-07-03 Scios Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000073498A1 (en) 1999-06-02 2000-12-07 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of immune disorders
FR2795823B1 (fr) 1999-07-01 2001-11-23 Inst Nat Sante Rech Med Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
US6323334B1 (en) 1999-09-24 2001-11-27 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding a 103 gene product and uses therefor
AU2001218871A1 (en) 2000-03-21 2001-10-03 Takao Arai Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same
FR2807170B1 (fr) 2000-03-30 2002-06-28 Sipal Charniere elastique a frottement reduit
JP2004506443A (ja) 2000-08-22 2004-03-04 ブライハム　アンド　ウィメンズ　ホスピタル　インコーポレーテッド 心血管状態の診断および処置
US7432060B2 (en) 2000-11-09 2008-10-07 The Brigham And Women's Hospital, Inc. Methods for diagnosis of cardiovascular disease
US6537221B2 (en) 2000-12-07 2003-03-25 Koninklijke Philips Electronics, N.V. Strain rate analysis in ultrasonic diagnostic images
FI20010019A (fi) 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
US20040253637A1 (en) 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
WO2002089657A2 (en) 2001-05-04 2002-11-14 Biosite, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
WO2003022987A2 (en) 2001-07-26 2003-03-20 Eos Biotechnology, Inc. Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
US6810284B1 (en) 2001-11-21 2004-10-26 Pacesetter, Inc. Implantable cardiac stimulation system and method for monitoring diastolic function
ES2573471T3 (es) 2002-05-09 2016-06-08 The Brigham And Women's Hospital, Inc. 1L1RL-1 como un marcador de enfermedades cardiovasculares
US8263325B2 (en) 2002-11-15 2012-09-11 Ottawa Heart Institute Research Corporation Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
US20070042978A1 (en) 2002-12-19 2007-02-22 Jean-Philippe Girard Nf-hev compositions and methods of use
US20040133079A1 (en) 2003-01-02 2004-07-08 Mazar Scott Thomas System and method for predicting patient health within a patient management system
US20040220155A1 (en) 2003-03-28 2004-11-04 Pharmacia Corporation Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
US20060257558A1 (en) 2003-10-31 2006-11-16 Hiroshi Nomura Plasma polymerization of atomically modified surfaces
EP2405023B1 (en) 2003-11-26 2014-01-08 Celera Corporation Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
US7781219B2 (en) 2003-12-05 2010-08-24 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
NZ549040A (en) 2004-02-17 2009-07-31 Schering Corp Use for interleukin-33 (IL33) and the IL-33 receptor complex
JP2005291899A (ja) 2004-03-31 2005-10-20 Akira Matsumori 心疾患の検査法
CA2595794A1 (en) 2005-01-24 2006-07-27 F. Hoffmann-La Roche Ag The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs
EP1731910A1 (en) 2005-06-07 2006-12-13 F. Hoffmann-La Roche Ag Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases
US20070021977A1 (en) 2005-07-19 2007-01-25 Witt Biomedical Corporation Automated system for capturing and archiving information to verify medical necessity of performing medical procedure
JP4820192B2 (ja) 2006-03-17 2011-11-24 一般財団法人化学及血清療法研究所 急性冠症候群でのａｄａｍｔｓ１３の測定と利用
JP5383480B2 (ja) 2006-04-24 2014-01-08 クリティカル ケア ダイアグノスティクス インコーポレイテッド 致死性の予測および重大な疾患の検出
WO2007143295A2 (en) 2006-04-27 2007-12-13 Critical Care Diagnostics, Inc. Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
EP2482078B1 (en) * 2006-05-01 2016-02-03 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
HUE025058T2 (en) 2006-05-02 2016-01-28 Critical Care Diagnostics Inc Differential diagnosis of pulmonary and cardiovascular disease
WO2007130627A2 (en) 2006-05-04 2007-11-15 The Brigham And Women's Hospital, Inc. Il-33 in the treatment and diagnosis of diseases and disorders
RU2312591C1 (ru) 2006-06-14 2007-12-20 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования развития риска внезапной смерти у больных с лево- и правожелудочковой экстрасистолией
CA2554659A1 (en) * 2006-07-25 2006-11-24 1128971 Alberta Ltd. Hanger flange for hanging a tubular body in a well
US20080233191A1 (en) * 2007-03-22 2008-09-25 Brent Blackburn Use of ranolazine for elevated brain-type natriuretic peptide
US20090111708A1 (en) * 2007-05-11 2009-04-30 Seddon Johanna M Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk
WO2009040133A1 (en) * 2007-09-26 2009-04-02 Universitätsklinikum Heidelberg Osteopontin as novel prognostic biomarker for heart failure
FR2923029B1 (fr) 2007-10-26 2009-11-20 Minima Lunettes de type sans entourage a branches filaires
WO2009075566A1 (en) * 2007-12-12 2009-06-18 Erasmus University Medical Center Rotterdam Biomarkers for cardiovascular disease
EP3093663B1 (en) 2008-04-18 2018-06-13 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
JP5584695B2 (ja) * 2008-11-11 2014-09-03 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング Ａｄｍ及びｂｎｐのレベルを決定することによる心疾患に罹患した患者の予後診断及びリスク評価
CA2765516A1 (en) * 2009-07-01 2011-01-06 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for predicting cardiovascular mortality risk
AU2010319290A1 (en) * 2009-11-13 2012-05-24 Bg Medicine, Inc. Risk factors and prediction of myocardial infarction
US8258456B2 (en) * 2009-11-27 2012-09-04 Himax Imaging, Inc. Image sensor
EP2556090B1 (en) 2010-04-09 2016-02-24 Critical Care Diagnostics, Inc. Soluble human st-2 antibodies and assays
CN103328976B (zh) * 2010-11-01 2016-08-10 B.R.A.H.M.S有限公司 具有非特定主诉的患者的预后和风险评估
RU2452394C1 (ru) 2010-11-09 2012-06-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Ульяновский государственный университет Способ прогнозирования риска смерти больных хронической сердечной недостаточностью
CN106940375B (zh) 2011-03-17 2019-03-08 重症监护诊断股份有限公司 预测不良临床结果的风险的方法
DK2734222T3 (en) 2011-07-18 2017-01-30 Critical Care Diagnostics Inc PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY
EP3434260A1 (en) 2012-05-18 2019-01-30 Critical Care Diagnostics, Inc. Methods for treating or predicting risk of ventricular tachyarrhythmia event
WO2014028875A1 (en) 2012-08-16 2014-02-20 Critical Care Diagnostics, Inc. Methods for predicting risk of developing hypertension
SG11201501271TA (en) 2012-08-21 2015-03-30 Critical Care Diagnostics Inc Multimarker risk stratification
JP6178687B2 (ja) 2013-09-27 2017-08-09 富士機械工業株式会社 グラビア塗工装置
CA2935958A1 (en) 2014-01-10 2015-07-16 Critical Care Diagnostics, Inc. Methods and systems for determining risk of heart failure
USD770057S1 (en) 2014-04-14 2016-10-25 Critical Care Diagnostics, Inc. Blood test kit
US9934249B2 (en) 2014-06-03 2018-04-03 Conduent Business Machines Services, Llc Systems and methods for context-aware and personalized access to visualizations of road events
USD800333S1 (en) 2014-09-23 2017-10-17 Critical Care Diagnostics, Inc. Blood test kit
USD800332S1 (en) 2014-09-23 2017-10-17 Critical Care Diagnostics, Inc. Blood test kit
US10324089B2 (en) 2014-12-11 2019-06-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker
US10079073B2 (en) 2014-12-11 2018-09-18 Critical Care Diagnostics, Inc. Test apparatus and methods for ST2 cardiac biomarker

Also Published As

Publication number Publication date
AU2021202116A1 (en) 2021-05-06
MX2020009943A (es) 2020-10-16
JP6621520B2 (ja) 2019-12-18
EP2888687A1 (en) 2015-07-01
US10303844B2 (en) 2019-05-28
EP2888687A4 (en) 2016-04-13
EP2888687B1 (en) 2023-08-02
RU2015110054A (ru) 2016-10-10
JP2019053086A (ja) 2019-04-04
US20170169179A1 (en) 2017-06-15
JP6450679B2 (ja) 2019-01-09
US20140058743A1 (en) 2014-02-27
MX2015002254A (es) 2015-05-08
CA2882303A1 (en) 2014-02-27
CN111834009A (zh) 2020-10-27
JP2015532715A (ja) 2015-11-12
HK1212057A1 (en) 2016-06-03
IN2015DN01767A (ja) 2015-05-29
AU2019201709A1 (en) 2019-04-04
AU2019201709B2 (en) 2021-01-07
US20190237197A1 (en) 2019-08-01
US20200335220A1 (en) 2020-10-22
AU2013305829A1 (en) 2015-03-05
JP6902083B2 (ja) 2021-07-14
US10741290B2 (en) 2020-08-11
SG11201501271TA (en) 2015-03-30
CN104737170A (zh) 2015-06-24
JP2020034573A (ja) 2020-03-05
SG10201608854TA (en) 2016-12-29
WO2014031764A1 (en) 2014-02-27

Similar Documents

Publication Publication Date Title
HK1212057A1 (en) Multimarker risk stratification
HK1211623A1 (en) Cell lines
DK3327112T3 (en) Agse-deficient stamme
ZA201503358B (en) Structure
DK2830816T3 (en) Hidtil ukendt coatingkoncept
EP2896914A4 (en) ACCUMULATOR
AU347859S (en) Battery
AU346864S (en) Battery
EP2824749A4 (en) BATTERY WITH A COATED STRUCTURE
EP2939306A4 (en) DRUMS
GB201411223D0 (en) None
EP2911230A4 (en) CELL
EP2829738A4 (en) ACCUMULATOR
EP2831949A4 (en) SODIUM OXYGEN CELLS
EP2860406A4 (en) ACCUMULATOR
GB201319035D0 (en) Spolier structure
EP2872891A4 (en) STRATIFICATION OF THE RISK ASSOCIATED WITH INFLUENZA
EP2865898A4 (en) ACCUMULATOR
HK1206718A1 (en) Azaindolines
EP2939294A4 (en) DRUMS
PL2864290T3 (pl) 3-o-heteroaryloingenol
HUP1300640A2 (en) Belt-mounting structure
EP2906215A4 (en) SUITS
EP2871919A4 (en) STRUCTURE
GB201704907D0 (en) Storage